Medical Support | Societal Sustainability | Taiwan Blood Services Foundation ESG
Societal Sustainability
Medical support
Non-stop virus prevention
In order to provide high-quality blood products, we update the information on infection risk areas in real-time based on the international outbreak situation and recommendation levels announced by the Centers for Disease Control, Ministry of Health and Welfare, and information related to travel medicine, to ensure the safety of blood products from the source.
Prevention of Mpox
Efforts in virus prevention: Although the COVID-19 pandemic has subsided, we must not relax our pace in virus prevention. In response to the domestic Mpox outbreak, we have formulated the relevant control measures in accordance with the "Mpox Prevention and Control Manual" of the Centers for Disease Control on May 29, 2023, guarding the safety of blood use carefully.
|
Disease name/Symptom |
Duration of Postponement |
Reason for Postponement |
|---|---|---|
|
Close contacts of confirmed cases of Mpox |
21 days |
According to the "Mpox Prevention and Control Manual (Version 2023.05.01)" of the Centers for Disease Control. |
|
After recovering from Mpox and asymptomatic |
21 days |
Prevention of Dengue Fever
In 2023, as the dengue fever epidemic spread, our foundation has adhered to the past epidemic prevention measures and carefully monitored the dengue fever epidemic to maintain blood safety.
|
Disease name/Symptom |
Duration of Postponement |
Reason for Postponement |
|---|---|---|
|
Patients who have had a fever and symptoms have subsided |
2 weeks |
According to the resolution of the "Zika virus and Dengue virus" prevention team meeting held by TBSF on September 29, 2016. |
|
From the date of confirmed Dengue fever cases reported by the Centers for Disease Control |
6 weeks |
|
|
After recovering from dengue fever and asymptomatic |
4 weeks |
According to Letter Ji-Guan-Fang-Zi No. 1050201036 issued by the Centers for Disease Control, Ministry of Health and Welfare dated August 19, 2016. 。 |
|
Departure from dengue fever outbreak areas |
4 weeks |
|
|
Contacts of confirmed cases of dengue fever (including those who have dengue fever patients at home or at work, or whose home or work environment is forcibly sprayed with disinfectant) |
4 weeks |
Grasp medical blood demands and improve the quality of blood used by patients.
1. Balancing the supply and demand of blood
In order to achieve the goal of balanced blood donation, the "Blood Donation Coordination Committee" is convened every year to analyze and review the blood supply and demand situation, and to set the blood donation target for the following year.
2. Understanding the demand for medical blood usage
To keep abreast of medical blood demands, each blood center pays visits to hospitals from time to time for communication. Each blood center holds at least one "blood supply symposium" every year to exchange opinions with hospitals and regularly analyze the trend of blood use in hospitals. This is aimed to meet the actual demand of hospitals and make effective deployment of blood to fully utilize the blood resources. At the same time, the management of the blood inventory is strengthened to maintain the safe stock of blood products.
3.Enhancing the quality and safety of blood transfusions
To improve the quality and safety of blood for patients receiving transfusion and to reduce transfusion reactions, we have fully supplied Leucocyte-Poor Red Blood Cells before storage in 2022. At the same time, in order to improve the precision of blood transfusion service, we assist the clinical transfusion of long-term transfusion patients. We have continued to test the red blood cell antigens of blood donors, including E, e, C, c, M, Mia, Jka, Jkb and other antigens labelled on blood bags, in order to provide blood products with matching antigens and reduce the incidence of clinical hemolytic transfusion reactions.
